Diseases of skin and subcutaneouse tissue. L00-L99
Conditions
Interventions
Intervention 1: In the group 1: cold compress are exerted on the injection site of 60 patients under treatment by subcutaneous Enoxaparin (60 mg), for 20 minutes, using a towel, just after every inje
Prevention
Treatment - Drugs
In the group 1: cold compress are exerted on the injection site of 60 patients under treatment by subcutaneous Enoxaparin (60 mg), for 20 minutes, using a towel, just after every injection in abdomen
In the group 2: in addition to exertion of cold compress on the injection site of 60 patients under treatment by subcutaneous Enoxaparin (60 mg), for 20 minutes just after every injection in abdomen,
Third group is called control group and dose not take any special action to these patients except routine injection of subcutaneous Enoxaparin.
Sponsors
Tehran Universiy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient do not be pregnant; has not any coagulation disorders; the patient has the written order for injection Enoxaparin 60mg by doctor per 12 hours; and there is not record of previous injections during last 24hours in his/her abdominal area. Exclusion criteria: The drug of Enoxaparin stopped by doctor or changed; there is bleeding in injection area.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The size of bruising at the injection site of subcutaneous Enoxaparin. Timepoint: Until 3 days after the injection. Method of measurement: Using a plastic ruler. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed